Vaccine Market to Drive Future Pharmaceutical Growth

PR Minds

Source: 29, 1st Floor, Patparganj Industrial Area, Delhi 92 > 06 July 2009 (E-Business)

Increasing R&D spending and blockbuster sales of vaccines like Prevnar & Gardasil have prompted the pharmaceutical majors to focus on the rapidly growing vaccine segment worldwide.

The worldwide vaccine market has undergone a rapid transformation phase over the last few years. In the present scenario, major pharmaceutical players are eyeing vaccine market for their growth. The global vaccine sales grew at a CAGR of around 28% during 2005-2008, reveals our new research report “Global Vaccine Market Forecast to 2012”.

According to the report, the leading pharmaceutical companies such as Sanofi Aventis, Glaxo Smith Kline, Merck and Wyeth made significant investments in R&D that brought the major turnaround in the market and the market size surpassed US$ 20 Billion in 2008. Also, the introduction of cancer and rotavirus vaccines helped the global vaccine market to boost significantly.

Some vaccines recorded high sales in a relatively shorter period of time; for example, the sales of Wyeth’s pneumococcal conjugate vaccine Prevnar reached US$ 700 Million in the US within 15 months of its launch, and tallied sales of more than US$ 2.7 Billion worldwide in 2008. Gardasil, Merck’s cervical cancer vaccine brand also listed itself in top five vaccine selling brand names recording impressive sales for the year.

We foresee more vaccines to enter into the market during the forecasted period. With the approval of the Sanofi Pasteur’s meningitis vaccine (and its release of six other inoculations including one for bird flu), we expect the vaccine sales to grow at a CAGR of around 13% during 2009-2012. We also anticipate significant investments to take place outside the US, which remains to be the leading vaccine market.

Our report is an outcome of the extensive study and thorough research of various aspects of the vaccine market. It covers the market by region, the emerging vaccine segments that are witnessing rising sales, and the upcoming vaccines that will change the market dynamics. Also, it forecasts about the emerging regions and segments based on the key developments taking place at the national as well as global level.

For FREE SAMPLE of this report visit:


About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today’s globally competitive environment. Visit


Author: Leslie Carol Botha

Author, publisher, radio talk show host and internationally recognized expert on women's hormone cycles. Social/political activist on Gardasil the HPV vaccine for adolescent girls. Co-author of "Understanding Your Mood, Mind and Hormone Cycle." Honorary advisory board member for the Foundation for the Study of Cycles and member of the Society for Menstrual Cycle Research.